(3-Acetyl-indol-1-yl)-acetic acid → (1R,3S,5S)-2-[2-(3-Acetyl-indol-1-yl)-acetyl]-5-hydroxymethyl-2-aza-bicyclo[3.1.0]hexane-3-carboxylic acid 3-chloro-2-fluoro-benzylamide
反応式
[Cl:1][C:2]1[C:3]([F:35])=[C:4]([CH:32]=[CH:33][CH:34]=1)[CH2:5][NH:6][C:7]([C@@H:9]1[CH2:14][C@:13]2([CH2:15][OH:16])[C@@H:11]([CH2:12]2)[N:10]1[C:17](=[O:31])[CH2:18][N:19]1[C:23]2=N[CH:25]=[CH:26][CH:27]=[C:22]2[C:21]([C:28](=[O:30])[CH3:29])=[CH:20]1)=[O:8].[C:36](C1C2C(=CC=CC=2)N(CC(O)=O)C=1)(=O)C>CCOC(C)=O>[Cl:1][C:2]1[C:3]([F:35])=[C:4]([CH:32]=[CH:33][CH:34]=1)[CH2:5][NH:6][C:7]([C@@H:9]1[CH2:14][C@:13]2([CH2:15][OH:16])[C@@H:11]([CH2:12]2)[N:10]1[C:17](=[O:31])[CH2:18][N:19]1[C:23]2[C:22](=[CH:27][CH:26]=[CH:25][CH:36]=2)[C:21]([C:28](=[O:30])[CH3:29])=[CH:20]1)=[O:8]参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
The title compound was prepared in 2 steps according to the procedure described for the preparation of Example 610 (1R,3S,5S)-2-[2-(3-acetyl-pyrrolo[2,3-b]pyridin-1-yl)-acetyl]-5-hydroxymethyl-2-aza-bicyclo[3.1.0]hexane-3-carboxylic acid 3-chloro-2-fluoro-benzylamide using (3-acetyl-indol-1-yl)-acetic acid instead of (3-acetyl-pyrrolo[2,3-b]pyridin-1-yl)-acetic acid. White powder. TLC, Rf (EtOAc)=0.05; MS (LC/MS): 498/500 [M+H]+, 520/522 [M+Na]+; tR (HPLC conditions f): 1.84 min.
後処理
- custom1.84 min.
出典と根拠
- ORDレコード
- ord-5f6886f126af4e1c83f2f4024a33ab2a
- 出典データセット
- uspto-grants-2015_07
- 特許番号
- US09085555B2
反応ノート
読み込み中…